Strategic Positioning in Biotech: Where Innovation Can Save Lives
VITA34 is the first bank for the storage of umbilical cord blood founded in Europe. With more than 43,000 blood bottles of newborns’ VITA34 is the largest privately owned blood bank in the German speaking region. VITA34 services its storage to parents that intend to biologically insure their child with the storage of their own blood. The company gives life long cryocon versation of umbilical cord blood which can serve as a future resource for stem cell therapies. The service of collection, shipment by courier, processing in sterile rooms, freezing, quality testing, and cryoconservation makes stem cell blood available to a physician whenever necessary. The costs are a fixed fee of 1,990 EUR, as well as an annual payment of 30 EUR per year starting after the first birthday of the child.
KeywordsUmbilical Cord Blood Stem Cell Therapy Strategic Position Cord Blood Stem Cell Umbilical Cord Blood Stem Cell
Unable to display preview. Download preview PDF.
- Burgelman, R.A.; Christensen, C.M.; Wheelwright, S.C.: Strategic Man agement of Technology and Innovation, 4th edition, New York, NY: McGraw Hill, 2004.Google Scholar
- Huff, A.S.; Floyd, S.W.; Sherman, H.D.; Terjesen, S.: Strategic Management, San Francisco, CA: John Wiley & Sons, 2008.Google Scholar
- Johnson, G.; Scholes, K.; Whittington, R.: Exploring Corporate Strategy: Text and Cases, 8th edition, Harlow: Pearson Education, 2007.Google Scholar
- Swayne, L.E.; Duncan, W.J.; Ginter, P.M.: Strategic Management of Health Care Organizations, 6th edition, Malden, MA: Blackwell Publishing, 2006.Google Scholar